Toronto, September 18, 2013 – Covington Strategic Capital Fund Inc. (“SCF”) announced today that it will submit to shareholders for their consideration and approval a proposal pursuant to which Covington Fund II Inc. (“Fund II”) will, if approved by SCF shareholders, acquire the assets and assume the liabilities of SCF. The proposal is structured such that following completion of the acquisition, shareholders of SCF would become shareholders of Fund II.
TORONTO: The CVCA - Canada’s Venture Capital & Private Equity Association, is pleased to announce that Chip Vallis is the recipient of CVCA’s 2013 ‘Community Leadership’ Award.
The purpose of CVCA’s ‘Community Leadership’ Award is to honour individual CVCA Members who have “given back to Community”. This Award serves to highlight that, in addition to supporting Canada’s economic productivity; our members also foster Strong Corporate Social Responsibility as a foundation to building solid, vibrant communities.
WALTHAM, Mass., February 4, 2013 - Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health information solutions, announced today that it has acquired Epocal, Inc., a provider of best-in-class technologies that support blood gas and electrolyte testing at the point of care.
TORONTO, Jan. 13, 2013 /CNW/ - Covington Capital Corporation ("Covington") and the Board of Directors for Covington Fund II Inc. (the "Fund") today announced that effective December 28, 2012 the Fund would no longer offer Class A shares for sale to investors. The Fund will remain open to redemptions.
MARKHAM, ON, Jan. 8, 2013 /CNW/ - Cytochroma today announced that it has entered into a definitive agreement with OPKO Health, Inc. (NYSE:OPK) under which Cytochroma, a privately held pharmaceutical company with operations in Markham, ON and Bannockburn, IL, will be acquired by OPKO.